Xenon Pharmaceuticals Inc. (NASDAQ:XENE) is Commodore Capital LP’s 2nd Largest Position

Commodore Capital LP raised its position in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 17.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,167,793 shares of the biopharmaceutical company’s stock after buying an additional 322,793 shares during the quarter. Xenon […]

Leave a Reply

Your email address will not be published.

Previous post Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares Bought by Commodore Capital LP
Next post Opinion: Borough Jails Must Move Forward, With Guidance From Impacted People